Your browser doesn't support javascript.
loading
Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies.
Abusukhun, Murad; Winkler, Martin S; Pöhlmann, Stefan; Moerer, Onnen; Meissner, Konrad; Tampe, Björn; Hofmann-Winkler, Heike; Bauer, Michael; Gräler, Markus H; Claus, Ralf A.
Afiliación
  • Abusukhun M; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
  • Winkler MS; Center for Molecular Biomedicine (CMB), Jena University Hospital, Jena, Germany.
  • Pöhlmann S; Department of Anesthesiology, Emergency and Intensive Care Medicine, University of Göttingen, Göttingen, Germany.
  • Moerer O; Infection Biology Unit, German Primate Center-Leibniz Institute for Primate Research, Göttingen, Germany.
  • Meissner K; Faculty of Biology and Psychology, University Göttingen, Göttingen, Germany.
  • Tampe B; Department of Anesthesiology, Emergency and Intensive Care Medicine, University of Göttingen, Göttingen, Germany.
  • Hofmann-Winkler H; Department of Anesthesiology, Emergency and Intensive Care Medicine, University of Göttingen, Göttingen, Germany.
  • Bauer M; Department of Nephrology, University of Göttingen, Göttingen, Germany.
  • Gräler MH; Infection Biology Unit, German Primate Center-Leibniz Institute for Primate Research, Göttingen, Germany.
  • Claus RA; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Front Immunol ; 12: 784989, 2021.
Article en En | MEDLINE | ID: mdl-34987511

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esfingomielina Fosfodiesterasa / Transducción de Señal / Ceramidas / COVID-19 Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esfingomielina Fosfodiesterasa / Transducción de Señal / Ceramidas / COVID-19 Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Alemania